Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations
Cancer Cell · 2026-11 · 44 (11) · 2267-2280.e5
DOI: 10.1016/j.ccell.2026.09.011 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cancer Cell, 2026-11. Verfasst von Xiuning Le und 38 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: xle1@mdanderson.org. Hauptthemen laut MEDLINE: Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, ErbB Receptors, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Troper Wojcicki Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: xle1@mdanderson.org.
- Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China.
- Harbin Medical University Cancer Hospital, Harbin, China.
- The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
- Institut Gustave Roussy, Department of Medical Oncology, Villejuif, France.
- Blacktown Cancer and Haematology Centre, Blacktown, NSW, Australia.
Förderung
- NCI NIH HHS
- Troper Wojcicki Foundation
Zitieren
APA
Le, X., Wang, J., Yu, Y., Zhao, Y., Planchard, D., Gao, B., Spira, A., Liu, J., Li, X., Gadgeel, S., Leighl, N., Zhang, J., Hayashi, H., Nishio, M., Mazieres, J., de Langen, A. J., Pérol, M., Yoh, K., Forster, M. D., …, & Riess, J. W. (2026). Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations. Cancer Cell, 44(11), 2267-2280.e5. https://doi.org/10.1016/j.ccell.2026.09.011
Vancouver
Le X, Wang J, Yu Y, Zhao Y, Planchard D, Gao B, et al. Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations. Cancer Cell. 2026;44(11):2267-2280.e5. doi:10.1016/j.ccell.2026.09.011
BibTeX
@article{Le2026,
author = {Le, Xiuning and Wang, Jie and Yu, Yan and Zhao, Yanqiu and Planchard, David and Gao, Bo and Spira, Alexander and Liu, Jingling and Li, Xingya and Gadgeel, Shirish and Leighl, Natasha and Zhang, Junqiang and Hayashi, Hidetoshi and Nishio, Makoto and Mazieres, Julien and de Langen, Adrianus Johannes and Pérol, Maurice and Yoh, Kiyotaka and Forster, Martin D and Goto, Yasushi and de Miguel Luken, Maria and Franco Perez, Fernando Fabio and Chu, Quincy and Parakh, Sagun and Nilsson, Monique B and Jiang, Yong and Hu, Tianhua and Wang, Cunlin and Baio, Nichole and Musib, Luna and Mounir, Zineb and Kowanetz, Marcin and Wang, Shirley and Yea, Steven and Hsu, Jerry and Lutzker, Stuart and Heymach, John V and Juan-Vidal, Oscar and Riess, Jonathan W},
title = {Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {11},
pages = {2267--2280.e5},
doi = {10.1016/j.ccell.2026.09.011}
}
EUVIMED